These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37541842)

  • 1. Association of Plasma Aβ
    Johnson EL; Sullivan KJ; Schneider ALC; Simino J; Mosley TH; Kucharska-Newton A; Knopman DS; Gottesman RF
    Neurology; 2023 Sep; 101(13):e1319-e1327. PubMed ID: 37541842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Midlife Plasma Amyloid-β Levels With Cognitive Impairment in Late Life: The ARIC Neurocognitive Study.
    Sullivan KJ; Blackshear C; Simino J; Tin A; Walker KA; Sharrett AR; Younkin S; Gottesman RF; Mielke MM; Knopman D; Windham BG; Griswold ME; Mosley TH
    Neurology; 2021 Sep; 97(11):e1123-e1131. PubMed ID: 34349010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Midlife Risk Factors and Late-Onset Epilepsy: Results From the Atherosclerosis Risk in Communities Study.
    Johnson EL; Krauss GL; Lee AK; Schneider ALC; Dearborn JL; Kucharska-Newton AM; Huang J; Alonso A; Gottesman RF
    JAMA Neurol; 2018 Nov; 75(11):1375-1382. PubMed ID: 30039175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevation of the Plasma Aβ40/Aβ42 Ratio as a Diagnostic Marker of Sporadic Early-Onset Alzheimer's Disease.
    Kim HJ; Park KW; Kim TE; Im JY; Shin HS; Kim S; Lee DH; Ye BS; Kim JH; Kim EJ; Park KH; Han HJ; Jeong JH; Choi SH; Park SA
    J Alzheimers Dis; 2015; 48(4):1043-50. PubMed ID: 26444752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma beta amyloid level and depression in older adults.
    Metti AL; Cauley JA; Newman AB; Ayonayon HN; Barry LC; Kuller LM; Satterfield S; Simonsick EM; Yaffe K
    J Gerontol A Biol Sci Med Sci; 2013 Jan; 68(1):74-9. PubMed ID: 22499763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of β-Amyloid, Microglial Activation, Cortical Thickness, and Metabolism in Older Adults Without Dementia.
    Cai Y; Shi D; Lan G; Chen L; Jiang Y; Zhou L; Guo T;
    Neurology; 2024 Apr; 102(7):e209205. PubMed ID: 38489560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A two-step immunoassay for the simultaneous assessment of Aβ38, Aβ40 and Aβ42 in human blood plasma supports the Aβ42/Aβ40 ratio as a promising biomarker candidate of Alzheimer's disease.
    Shahpasand-Kroner H; Klafki HW; Bauer C; Schuchhardt J; Hüttenrauch M; Stazi M; Bouter C; Wirths O; Vogelgsang J; Wiltfang J
    Alzheimers Res Ther; 2018 Dec; 10(1):121. PubMed ID: 30526652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ten-year change in plasma amyloid beta levels and late-life cognitive decline.
    Okereke OI; Xia W; Selkoe DJ; Grodstein F
    Arch Neurol; 2009 Oct; 66(10):1247-53. PubMed ID: 19822780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in Alzheimer Disease Blood Biomarkers and Associations With Incident All-Cause Dementia.
    Lu Y; Pike JR; Chen J; Walker KA; Sullivan KJ; Thyagarajan B; Mielke MM; Lutsey PL; Knopman D; Gottesman RF; Sharrett AR; Coresh J; Mosley TH; Palta P
    JAMA; 2024 Oct; 332(15):1258-1269. PubMed ID: 39068543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis.
    Schindler SE; Bollinger JG; Ovod V; Mawuenyega KG; Li Y; Gordon BA; Holtzman DM; Morris JC; Benzinger TLS; Xiong C; Fagan AM; Bateman RJ
    Neurology; 2019 Oct; 93(17):e1647-e1659. PubMed ID: 31371569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma and cerebrospinal fluid levels of amyloid beta proteins 1-40 and 1-42 in Alzheimer disease.
    Mehta PD; Pirttilä T; Mehta SP; Sersen EA; Aisen PS; Wisniewski HM
    Arch Neurol; 2000 Jan; 57(1):100-5. PubMed ID: 10634455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship of plasma Aβ levels to dementia in aging individuals with mild cognitive impairment.
    Fei M; Jianghua W; Rujuan M; Wei Z; Qian W
    J Neurol Sci; 2011 Jun; 305(1-2):92-6. PubMed ID: 21440911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of kidney function and CSF/serum albumin ratio on plasma Aβ42 and Aβ40 levels measured on a fully automated platform in patients with Alzheimer's disease.
    Verde F; Milone I; Dubini A; Colombrita C; Perego A; Solca F; Maranzano A; Ciusani E; Poletti B; Ratti A; Torresani E; Silani V; Ticozzi N
    Neurol Sci; 2023 Sep; 44(9):3287-3290. PubMed ID: 37284933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depression and plasma amyloid beta peptides in the elderly with and without the apolipoprotein E4 allele.
    Sun X; Chiu CC; Liebson E; Crivello NA; Wang L; Claunch J; Folstein M; Rosenberg I; Mwamburi DM; Peter I; Qiu WQ
    Alzheimer Dis Assoc Disord; 2009; 23(3):238-44. PubMed ID: 19812466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Head Injury With Late-Onset Epilepsy: Results From the Atherosclerosis Risk in Communities Cohort.
    Schneider ALC; Gottesman RF; Krauss GL; Gugger J; Diaz-Arrastia R; Kucharska-Newton A; Huang J; Johnson EL
    Neurology; 2022 Feb; 98(8):e808-e817. PubMed ID: 34921108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Additional use of Aβ₄₂/Aβ₄₀ ratio with cerebrospinal fluid biomarkers P-tau and Aβ₄₂ increases the level of evidence of Alzheimer's disease pathophysiological process in routine practice.
    Sauvée M; DidierLaurent G; Latarche C; Escanyé MC; Olivier JL; Malaplate-Armand C
    J Alzheimers Dis; 2014; 41(2):377-86. PubMed ID: 24614902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma Amyloid and in vivo Brain Amyloid in Late Middle-Aged Hispanics.
    Rippon B; Palta P; Tahmi M; Sherwood G; Soto L; Cespedes S; Mesen Y; He H; Laing K; Moreno H; Teresi J; Razlighi Q; Brickman AM; Zetterberg H; Luchsinger JA
    J Alzheimers Dis; 2022; 87(3):1229-1238. PubMed ID: 35466933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic Analysis Identifies Circulating Proteins Associated With Plasma Amyloid-β and Incident Dementia.
    Tin A; Sullivan KJ; Walker KA; Bressler J; Talluri R; Yu B; Simino J; Gudmundsdottir V; Emilsson V; Jennings LL; Launer L; Mei H; Boerwinkle E; Windham BG; Gottesman R; Gudnason V; Coresh J; Fornage M; Mosley TH
    Biol Psychiatry Glob Open Sci; 2023 Jul; 3(3):490-499. PubMed ID: 37519456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of time of the day at sampling on CSF and plasma levels of Alzheimer' disease biomarkers.
    Orduña Dolado A; Stomrud E; Ashton NJ; Nilsson J; Quijano-Rubio C; Jethwa A; Brum WS; Brinkmalm Westman A; Zetterberg H; Blennow K; Janelidze S; Hansson O
    Alzheimers Res Ther; 2024 Jun; 16(1):132. PubMed ID: 38909218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Race on Prediction of Brain Amyloidosis by Plasma Aβ42/Aβ40, Phosphorylated Tau, and Neurofilament Light.
    Schindler SE; Karikari TK; Ashton NJ; Henson RL; Yarasheski KE; West T; Meyer MR; Kirmess KM; Li Y; Saef B; Moulder KL; Bradford D; Fagan AM; Gordon BA; Benzinger TLS; Balls-Berry J; Bateman RJ; Xiong C; Zetterberg H; Blennow K; Morris JC
    Neurology; 2022 Jul; 99(3):e245-e257. PubMed ID: 35450967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.